PEGLYTE POWDER 5.85 G — DIN 00777838
SODIUM CHLORIDE : 5.85 G SODIUM BICARBONATE : 6.76 G POTASSIUM CHLORIDE : 3.05 G MACROGOL : 238.18 G SODIUM SULFATE : 22.96 G · PENDOPHARM DIVISION OF PHARMASCIENCE INC · POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is PEGLYTE POWDER?
PEGLYTE POWDER 5.85 G contains SODIUM CHLORIDE : 5.85 G SODIUM BICARBONATE : 6.76 G POTASSIUM CHLORIDE : 3.05 G MACROGOL : 238.18 G SODIUM SULFATE : 22.96 G. It is listed in the Health Canada Drug Product Database under DIN 00777838, held by PENDOPHARM DIVISION OF PHARMASCIENCE INC, supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as marketed, status dated 22-May-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PEGLYTE POWDER used for?
PegLyte® Powder (PEG 3350 and Electrolytes) is indicated for: • bowel cleansing prior to colonoscopy or barium enema x-ray examination or surgical procedures requiring a clean colon. • the treatment of constipation
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Mineral Salts In Combination cost around the world?
Mineral Salts In Combination is listed on 3 of the national price registers Nexara ingests. Each country publishes on a different basis, so figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Czechia publishes a max producer price (ex-factory); Greece publishes a producer price (ex-factory); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed |
|---|---|---|---|
| Czechia | max producer price (ex-factory) | 1 | 1 |
| Greece | producer price (ex-factory) | 1 | 1 |
| Luxembourg | reimbursement | 1 | 1 |
3 pack listings across 3 brand entries and 3 price bases, refreshed 05 Sep 2026. Ranges span every Mineral Salts In Combination pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Mineral Salts In Combination in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Mineral Salts In Combination, across 13 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 1 | 1 | PEGLYTE POWDER | Sourceable in Canada |
| GLENDALE AGENCIES | 2 | 0 | EAU PURGATIVE RIGA, RIGA PURGATIVE LEMON FLAV LIQ | No marketed DIN |
| PHARMASCIENCE INC | 2 | 0 | PEGLYTE SOLUTION, PMS-PEGLYTE | No marketed DIN |
| THERAPEX DIVISION DE E-Z-EM CANADA INC | 2 | 0 | LYTEPREP | No marketed DIN |
| ABBOTT LABORATORIES, LIMITED | 1 | 0 | OCL SOLUTION | No marketed DIN |
| BEUTLICH L.P. | 1 | 0 | CEO-TWO BOWEL EVACUANT SUPPOSITORIES | No marketed DIN |
| BRAINTREE LABORATORIES INC. | 1 | 0 | GOLYTELY GI LAVAGE SOLUTION | No marketed DIN |
| RICHMOND PHARMACEUTICALS INC. | 1 | 0 | KLEAN-PREP | No marketed DIN |
| RIVEX PHARMA INC. | 1 | 0 | PROLAX - PWS | No marketed DIN |
| TECHNILAB PHARMA INC. | 1 | 0 | ELECTROPEG SOLUTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 5.85 G |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | ORAL |
| Pack configuration (monograph) | 280 g bottle, Box of 4 x 70 g sachets |
| Storage | Store the sachets and bottle at room temperature, between 15°C and 30°C. Once reconstituted, the solution should be used within 48 hours after mixing if stored at room temperature. If kept refrigerated (2°C to 8°C), use within 30 days. Discard unused portion. |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Substance and classification
| Active substance | Mineral Salts In Combination |
|---|---|
| ATC code | A06AD10 |
| AHFS class | 56:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00777838 |
|---|---|
| DIN (unpadded, as printed on some documents) | 777838 |
| Brand name | PEGLYTE POWDER |
| Generic / active ingredient | SODIUM CHLORIDE : 5.85 G SODIUM BICARBONATE : 6.76 G POTASSIUM CHLORIDE : 3.05 G MACROGOL : 238.18 G SODIUM SULFATE : 22.96 G |
| Market authorization holder | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Health Canada schedule | Ethical |
| ATC code | A06AD10 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AD |
| Current status | MARKETED |
| Status date | 22-May-2013 |
| Original market date | 1988-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 13 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CEO-TWO BOWEL EVACUANT SUPPOSITORIES | 627 MG | SUPPOSITORY | BEUTLICH L.P. | CANCELLED POST MARKET | 02090074 |
| EAU PURGATIVE RIGA | 2.4 G / 30 ML | LIQUID | GLENDALE AGENCIES | CANCELLED POST MARKET | 00421359 |
| ELECTROPEG SOLUTION | 6.7 G / 277 G | POWDER | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | 02230825 |
| GOLYTELY GI LAVAGE SOLUTION | 22.74 G / 4 L | POWDER FOR SOLUTION | BRAINTREE LABORATORIES INC. | CANCELLED POST MARKET | 00652512 |
| KLEAN-PREP | 740 MG | POWDER FOR SOLUTION | RICHMOND PHARMACEUTICALS INC. | CANCELLED POST MARKET | 00741175 |
| LYTEPREP | 25 MMOL | POWDER FOR SOLUTION | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | 00695335 |
| LYTEPREP | 2.97 G | POWDER | THERAPEX DIVISION DE E-Z-EM CANADA INC | CANCELLED POST MARKET | 02239569 |
| OCL SOLUTION | 1.68 MG | SOLUTION | ABBOTT LABORATORIES, LIMITED | CANCELLED POST MARKET | 00709298 |
| PEGLYTE SOLUTION | 1.46 G | LIQUID | PHARMASCIENCE INC | CANCELLED POST MARKET | 00777846 |
| PMS-PEGLYTE | 3.05 G | POWDER FOR SOLUTION | PHARMASCIENCE INC | APPROVED | 02471590 |
2 · Same class — other molecules in ATC A06AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Macrogol | CLARILAX · CLEARLAX · COLAXOR · COMFILAX · +17 more | 22 | 12 | Yes |
| Lactulose | CEPHULAC SYR 667MG/ML · CHRONULAC SYR · CHRONULAC SYR 667MG/ML · COMALOSE R SIROP 10GM/15ML · +20 more | 28 | 5 | Yes |
| Macrogol, Combinations | COLYTE · JAMP-ELECTROPEG · JAMP-ELECTROPEG WITH FLAVOUR PACKET · JAMPLYTE · +3 more | 8 | 3 | Yes |
| Mineral Salts In Combination | CEO-TWO BOWEL EVACUANT SUPPOSITORIES · EAU PURGATIVE RIGA · ELECTROPEG SOLUTION · GOLYTELY GI LAVAGE SOLUTION · +8 more | 13 | 1 | Yes |
| Magnesium Sulphate | EPSOM SALT PWS 100% · EPSOM SALTS · SEL D EPSOM | 6 | 0 | Not in Canada |
| Magnesium Sulphate, Combinations | AGOBYL GRANULE · AGOBYL LIQUIDE · FORMULE 1705 - LIQ | 3 | 0 | Not in Canada |
| Sodium Phosphate | EURO-PHOSPHATES SOLUTION · PHOSPHO-SODA BUFFERED SALINE LAXATIVE · PMS-PHOSPHATES SOLUTION | 3 | 0 | Not in Canada |
| Sorbitol | SORBITOL ROUGIER PWS 5GM | 1 | 0 | Not in Canada |
| Sodium Tartrate | LIMONADE RODECA | 1 | 0 | Not in Canada |
| Magnesium Oxide | MAGNESIUM CITRATE ORAL SOLUTION | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AB | Bisacodyl · Bisacodyl, Combinations · Cascara · Cascara, Combinations · Castor Oil · +9 more | 239 | 25 |
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AX | Glycerol · Linaclotide · Lubiprostone · Other Laxatives · Plecanatide · +2 more | 30 | 14 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PEGLYTE POWDER called?
The same molecule, Mineral Salts In Combination, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| EZICLEN | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.